Navigation Links
Misleading Advertisements for Prescription Drugs

In direct-to-consumer advertisements of prescription drugs, statements about drug benefits are often overblown and misleading. "These advertisements rarely quantify the medications' expected benefit; instead, they make an emotional appeal," Dr. Steven Woloshin from Dartmouth Medical School, Hanover, New Hampshire. //

Instead of telling the consumer how likely it is that the medicine is going to prevent some outcome, these advertisement often use vague qualitative messages, such as "Try it, it works," or "Take the drug and be there for your future," he said.

Dr. Woloshin and colleagues did a content analysis of 67 direct-to consumer prescription drug advertisements that collectively appeared 211 times in 10 consumer magazines in the US over a year's time. The ads "not only targeted symptom relief but also treatment and prevention of disease," Dr. Woloshin noted. Sixty-three percent were for drugs that relieve symptoms, 26% for drugs to treat disease and 11% for drugs to prevent disease.

He pointed out that proponents of direct-to-consumer drug ads argue that the ads help educate consumers about treatment options and increase the awareness of the consequence of disease. Dr. Woloshin's group proposes that the US Food and Drug Administration mandate a standard format for summarizing the information about a drug in advertisements.


Page: 1

Related medicine news :

1. Misleading anti-malarial drug
2. The Effects Of Smoking Misleading
3. Lifting The Screen off Misleading Sunscreen labels
4. Misleading Health Claims On Food Labels No Longer Allowed in EU
5. Walkers Crisps Advertisements make Misleading Claims about Salt Content
6. Medical Council Of India Draws Public Attention on Misleading Ads.
7. Obesity Drug Advertisements Misleading Teens
8. Labeling of Dairy Products with Trans fat labels, Misleading to Consumers
9. Madras High Court Disapproves of Comparative Advertisements
10. Advertisements Prompt Youth To Drink
11. Advertisements in High School Newspapers Encourage Students to Sport a Tan
Post Your Comments:

(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: